Cargando…
The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer
BACKGROUND: Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages. METH...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161249/ https://www.ncbi.nlm.nih.gov/pubmed/32293339 http://dx.doi.org/10.1186/s12885-020-06839-9 |
_version_ | 1783522922902585344 |
---|---|
author | Chan, Man-Yee Lee, Bor-Jen Chang, Po-Sheng Hsiao, Han-Yu Hsu, Li-Ping Chang, Chia-Hua Lin, Ping-Ting |
author_facet | Chan, Man-Yee Lee, Bor-Jen Chang, Po-Sheng Hsiao, Han-Yu Hsu, Li-Ping Chang, Chia-Hua Lin, Ping-Ting |
author_sort | Chan, Man-Yee |
collection | PubMed |
description | BACKGROUND: Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages. METHODS: A total of 194 patients with oral cancer were enrolled in this study. The patients were stratified for four groups according to cancer stages and that the statistics are comparisons across these groups. The levels of antioxidant vitamins (ubiquinone, β-carotene, vitamin A and E), metabolic parameters, oxidative stress, antioxidant enzymes activity, and inflammatory markers were measured. RESULTS: More than half of the subjects had high blood pressure, central obesity, hyperglycemia, and hyperlipidemia regardless of TNM stage. With regard to antioxidant vitamins status, 46 and 94% of patients had β-carotene and ubiquinone deficiency, respectively. Patients in T3 and T4 stages had significantly lower antioxidant enzyme (catalase, p = 0.03) activity and higher inflammatory markers levels (high sensitivity C-reactive protein and interleukin-6, p < 0.01) than patients in the other stages. In addition, the level of β-carotene was negatively associated with waist circumference, and ubiquinone was positively associated with the level of high-density lipoprotein cholesterol (p < 0.05). Higher β-carotene and ubiquinone levels were negatively associated with hypertriglyceridemia and the risk of metabolic syndrome (p < 0.05). CONCLUSIONS: A high proportion of patients with oral cancer had ubiquinone or β-carotene deficiency and metabolic disorders. The level of ubiquinone or β-carotene was negatively associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome. Since patients with oral cancer suffer from high oxidative stress and inflammation (particularly in the T3 and T4 stages), supplementation with antioxidant vitamins such as ubiquinone or β-carotene could be preferentially applied. |
format | Online Article Text |
id | pubmed-7161249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71612492020-04-22 The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer Chan, Man-Yee Lee, Bor-Jen Chang, Po-Sheng Hsiao, Han-Yu Hsu, Li-Ping Chang, Chia-Hua Lin, Ping-Ting BMC Cancer Research Article BACKGROUND: Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages. METHODS: A total of 194 patients with oral cancer were enrolled in this study. The patients were stratified for four groups according to cancer stages and that the statistics are comparisons across these groups. The levels of antioxidant vitamins (ubiquinone, β-carotene, vitamin A and E), metabolic parameters, oxidative stress, antioxidant enzymes activity, and inflammatory markers were measured. RESULTS: More than half of the subjects had high blood pressure, central obesity, hyperglycemia, and hyperlipidemia regardless of TNM stage. With regard to antioxidant vitamins status, 46 and 94% of patients had β-carotene and ubiquinone deficiency, respectively. Patients in T3 and T4 stages had significantly lower antioxidant enzyme (catalase, p = 0.03) activity and higher inflammatory markers levels (high sensitivity C-reactive protein and interleukin-6, p < 0.01) than patients in the other stages. In addition, the level of β-carotene was negatively associated with waist circumference, and ubiquinone was positively associated with the level of high-density lipoprotein cholesterol (p < 0.05). Higher β-carotene and ubiquinone levels were negatively associated with hypertriglyceridemia and the risk of metabolic syndrome (p < 0.05). CONCLUSIONS: A high proportion of patients with oral cancer had ubiquinone or β-carotene deficiency and metabolic disorders. The level of ubiquinone or β-carotene was negatively associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome. Since patients with oral cancer suffer from high oxidative stress and inflammation (particularly in the T3 and T4 stages), supplementation with antioxidant vitamins such as ubiquinone or β-carotene could be preferentially applied. BioMed Central 2020-04-15 /pmc/articles/PMC7161249/ /pubmed/32293339 http://dx.doi.org/10.1186/s12885-020-06839-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Chan, Man-Yee Lee, Bor-Jen Chang, Po-Sheng Hsiao, Han-Yu Hsu, Li-Ping Chang, Chia-Hua Lin, Ping-Ting The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
title | The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
title_full | The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
title_fullStr | The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
title_full_unstemmed | The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
title_short | The risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
title_sort | risks of ubiquinone and β-carotene deficiency and metabolic disorders in patients with oral cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161249/ https://www.ncbi.nlm.nih.gov/pubmed/32293339 http://dx.doi.org/10.1186/s12885-020-06839-9 |
work_keys_str_mv | AT chanmanyee therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT leeborjen therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT changposheng therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT hsiaohanyu therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT hsuliping therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT changchiahua therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT linpingting therisksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT chanmanyee risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT leeborjen risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT changposheng risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT hsiaohanyu risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT hsuliping risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT changchiahua risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer AT linpingting risksofubiquinoneandbcarotenedeficiencyandmetabolicdisordersinpatientswithoralcancer |